You are here

Article info

Article menu
Heart failure and cardiomyopathies
Original research
Direct and indirect effect of the COVID-19 pandemic on patients with cardiomyopathy

Authors

  • Daniel J Hammersley National Heart and Lung Institute, Imperial College London, London, UKCardiovascular Research Centre, Royal Brompton and Harefield Clinical Group, Guy’s and St Thomas’ NHS Foundation Trust, London, UK PubMed articlesGoogle scholar articles
  • Rachel J Buchan National Heart and Lung Institute, Imperial College London, London, UKCardiovascular Research Centre, Royal Brompton and Harefield Clinical Group, Guy’s and St Thomas’ NHS Foundation Trust, London, UKMRC London Institute of Medical Sciences, Imperial College, London, UK PubMed articlesGoogle scholar articles
  • Amrit S Lota National Heart and Lung Institute, Imperial College London, London, UKCardiovascular Research Centre, Royal Brompton and Harefield Clinical Group, Guy’s and St Thomas’ NHS Foundation Trust, London, UK PubMed articlesGoogle scholar articles
  • Lukas Mach National Heart and Lung Institute, Imperial College London, London, UKCardiovascular Research Centre, Royal Brompton and Harefield Clinical Group, Guy’s and St Thomas’ NHS Foundation Trust, London, UK PubMed articlesGoogle scholar articles
  • Richard E Jones National Heart and Lung Institute, Imperial College London, London, UKCardiovascular Research Centre, Royal Brompton and Harefield Clinical Group, Guy’s and St Thomas’ NHS Foundation Trust, London, UK PubMed articlesGoogle scholar articles
  • Brian P Halliday National Heart and Lung Institute, Imperial College London, London, UKCardiovascular Research Centre, Royal Brompton and Harefield Clinical Group, Guy’s and St Thomas’ NHS Foundation Trust, London, UK PubMed articlesGoogle scholar articles
  • Upasana Tayal National Heart and Lung Institute, Imperial College London, London, UKCardiovascular Research Centre, Royal Brompton and Harefield Clinical Group, Guy’s and St Thomas’ NHS Foundation Trust, London, UK PubMed articlesGoogle scholar articles
  • Devendra Meena Department of Epidemiology and Biostatistics, Imperial College London School of Public Health, London, UK PubMed articlesGoogle scholar articles
  • Abbas Dehghan Department of Epidemiology and Biostatistics, Imperial College London School of Public Health, London, UK PubMed articlesGoogle scholar articles
  • Ioanna Tzoulaki Department of Epidemiology and Biostatistics, Imperial College London School of Public Health, London, UKBritish Heart Foundation Centre of Excellence, Imperial College London, London, UKDepartment of Hygiene and Epidemiology, University of Ioannina, Ioannina, Greece PubMed articlesGoogle scholar articles
  • A John Baksi Cardiovascular Research Centre, Royal Brompton and Harefield Clinical Group, Guy’s and St Thomas’ NHS Foundation Trust, London, UK PubMed articlesGoogle scholar articles
  • Antonis Pantazis Cardiovascular Research Centre, Royal Brompton and Harefield Clinical Group, Guy’s and St Thomas’ NHS Foundation Trust, London, UK PubMed articlesGoogle scholar articles
  • Angharad M Roberts National Heart and Lung Institute, Imperial College London, London, UKCardiovascular Research Centre, Royal Brompton and Harefield Clinical Group, Guy’s and St Thomas’ NHS Foundation Trust, London, UK PubMed articlesGoogle scholar articles
  • Sanjay K Prasad National Heart and Lung Institute, Imperial College London, London, UKCardiovascular Research Centre, Royal Brompton and Harefield Clinical Group, Guy’s and St Thomas’ NHS Foundation Trust, London, UK PubMed articlesGoogle scholar articles
  • James S Ware National Heart and Lung Institute, Imperial College London, London, UKCardiovascular Research Centre, Royal Brompton and Harefield Clinical Group, Guy’s and St Thomas’ NHS Foundation Trust, London, UKMRC London Institute of Medical Sciences, Imperial College, London, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Dr James S Ware; j.ware{at}imperial.ac.uk
View Full Text

Citation

Hammersley DJ, Buchan RJ, Lota AS, et al
Direct and indirect effect of the COVID-19 pandemic on patients with cardiomyopathy
Open Heart 2022;9:e001918. doi: 10.1136/openhrt-2021-001918

Publication history

  • Received December 14, 2021
  • Accepted January 4, 2022
  • First published January 27, 2022.
Online issue publication 
January 27, 2022

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.